<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>CEVA trial confirms efficacy of Tiludronate for the treatment of bone spavin</title><link>/b/veterinary-nursing-news/posts/90123</link><description> CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>